Venture Capital

The state of investment: 'biotech is up'

Dispatches from BIO 2016

The state of investment: 'biotech is up'

By Melissa Fassbender

The biopharmaceutical industry broke several records in 2015 – but to continue the trend will require a sustained investment from multiple stakeholders.

Architects' plans for the Nottingham, UK facility

$47m innovation facility built in Nottingham, UK

By Fiona BARRY

The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture capital fund which will invest in the SME tenants.

PCI’s CEO Bill Mitchell told Outsourcing-Pharma.com he plans to have the two firms continue to operate as distinct companies

Packaging firm PCI buys Welsh CDMO for $215m

By Fiona BARRY

Packaging Coordinators Inc (PCI) has announced its acquisition of Welsh contract development and manufacturing organisation (CDMO) Penn Pharmaceutical Services in a £127m ($215m) deal.

Private equity to buy SeraCare

Private equity to buy SeraCare

By Nick Taylor

SeraCare Life Sciences has accepted an $82m offer from a US private equity firm six months after it began searching for a buyer.

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All